Page last updated: 2024-09-05

zm 241385 and Cancer of Prostate

zm 241385 has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Christopoulos, A; Gregory, KJ; May, LT; Tan, CY; Vecchio, EA; White, PJ	1

Other Studies

1 other study(ies) available for zm 241385 and Cancer of Prostate

Article	Year
Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation. The Journal of pharmacology and experimental therapeutics, 2016, Volume: 357, Issue:1 Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Deaminase; Animals; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Drug Design; Humans; Inositol Phosphates; Ligands; Male; MAP Kinase Signaling System; Prostatic Neoplasms; Receptor, Adenosine A2B; Signal Transduction; Sulfonamides; Triazines; Triazoles; Xanthines	2016

Article

Year

Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.

The Journal of pharmacology and experimental therapeutics, 2016, Volume: 357, Issue:1

Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Deaminase; Animals; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Drug Design; Humans; Inositol Phosphates; Ligands; Male; MAP Kinase Signaling System; Prostatic Neoplasms; Receptor, Adenosine A2B; Signal Transduction; Sulfonamides; Triazines; Triazoles; Xanthines

2016